1.29
0.09 (7.50%)
| Previous Close | 1.20 |
| Open | 1.22 |
| Volume | 329,001 |
| Avg. Volume (3M) | 658,336 |
| Market Cap | 32,669,636 |
| Price / Sales | 0.760 |
| 52 Weeks Range | |
| Earnings Date | 27 Mar 2025 |
| Profit Margin | -51.77% |
| Operating Margin (TTM) | -14.61% |
| Diluted EPS (TTM) | -0.850 |
| Quarterly Revenue Growth (YOY) | 43.80% |
| Current Ratio (MRQ) | 0.570 |
| Operating Cash Flow (TTM) | -9.20 M |
| Levered Free Cash Flow (TTM) | 1.57 M |
| Return on Assets (TTM) | -36.11% |
| Return on Equity (TTM) | -2,308.32% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Spectral AI, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -0.5 |
| Average | 1.25 |
|
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient’s wound. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 32.11% |
| % Held by Institutions | 13.09% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Highlander Partners, L.P. | 31 Dec 2024 | 900,000 |
| University Of Texas/Texas Am Investment Management Co | 31 Dec 2024 | 210,488 |
| Millington Financial Advisors, Llc | 31 Dec 2024 | 30,000 |
| Forum Financial Management, Lp | 31 Dec 2024 | 29,098 |
| 52 Weeks Range | ||
| Median | 3.50 (171.32%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 02 Apr 2025 | 3.50 (171.32%) | Buy | 1.29 |
| 18 Mar 2025 | 3.50 (171.32%) | Buy | 1.68 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |